We held the second Swiss HLG Start-Up Initiative workshop on June 12, kindly hosted by Johnson & Johnson at their new campus in Allschwil. This initiative is a collaboration between Swiss HLG, BaseLaunch and Johnson & Johnson and aims to help 30 great biotech start-ups get Fit for Partnering through a series of four linked workshops. At the June workshop nine brave start-ups pitched to an expert jury, including Johnson & Johnson, Novartis, Roche, Pureos Bioventures and Forty51 Ventures. We are enormously grateful for the thoughtful insights provided by Anthony Gemmell, Markus Werner, Alessandra Polara, Ying Wang, Anne Grahl and Sara Núñez-Garcia, PhD, MBA. And big thanks to our Board member Michael R Huebner for being a fantastic organiser and host. The quality of the pitches was impressive and we would like to thank the wonderful start-ups for pitching: - Amporin Pharmaceuticals - Antion Biosciences SA - Ariya Bio - Barrier Therapeutics - T-Oncology AG - ILONOV - MT-act - Selmod - FatiAbGen Inc. It was a fantastic event with a great atmosphere and we are keenly looking forward to the next workshop in September, which will dive into partnering and term sheet negotiations.
Sarah Holland
3mo
The future of biotech innovation is in great hands - big thanks to Michael R Huebner, Francesca Lianza and Martyna Wroblewska for the fantastic collaboration and to our wonderful panel.
Same here, excellent initiative with high level insights. Thank you for this opportunity Swiss HLG !
Bio-Innovator | Cell & Gene Therapy Enthusiast | Former CEO and Board Member
3moA big thanks to Swiss HLG and this excellent initiative to transfer priceless insights from industry professionals to startups in Biotech. A notable thank you to Johnson & Johnson, BaseLaunch, Novartis, Roche, Pureos Bioventures, Forty51 Ventures for their precious time and candid feedback on our pitches! It goes without saying, I would strongly recommend and encourage Swiss healthcare and biotech startups to attend and listen intensely to secrets of the industry 😉.